Home/Filings/4/0000874716-25-000135
4//SEC Filing

Underberg Sharon E. 4

Accession 0000874716-25-000135

CIK 0000874716other

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 5:00 PM ET

Size

11.9 KB

Accession

0000874716-25-000135

Insider Transaction Report

Form 4
Period: 2025-08-08
Underberg Sharon E.
EVP, GC & Corporate Secretary
Transactions
  • Exercise/Conversion

    Incentive Stock Option (right-to-buy)

    2025-08-121830 total
    Exercise: $544.08Exp: 2031-02-13Common Stock (183 underlying)
  • Exercise/Conversion

    Common Stock

    2025-08-08$206.94/sh+5,450$1,127,82311,605.654 total
  • Sale

    Common Stock

    2025-08-08$651.60/sh5,450$3,551,2206,155.654 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right-to-buy)

    2025-08-085,4500 total
    Exercise: $206.94Exp: 2029-02-13Common Stock (5,450 underlying)
  • Exercise/Conversion

    Common Stock

    2025-08-12$544.08/sh+183$99,5676,338.654 total
Footnotes (3)
  • [F1]Includes a total of 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
  • [F2]Grant of option to buy shares of Issuer common stock that became exercisable in four annual installments beginning on February 14, 2020.
  • [F3]Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2025.

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0001630353

Filing Metadata

Form type
4
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 5:00 PM ET
Size
11.9 KB